Azor Biotek

Azor Biotek is developing microRNA-targeting small molecule therapeutics. Our lead therapeutics are designed to target miR-29 and miR-223 as multimodal tumor inhibitors. Our design platform leverages high-throughput zebrafish phenotypic, molecular and pharmacokinetic data. We have therapeutic devel... Read more